» Articles » PMID: 36312355

Synthesis and Characterization of Functionalized Amino Dihydropyrimidines Toward the Analysis of Their Antibacterial Structure-Activity Relationships and Mechanism of Action

Overview
Journal ACS Omega
Specialty Chemistry
Date 2022 Oct 31
PMID 36312355
Authors
Affiliations
Soon will be listed here.
Abstract

Antibiotic resistance among bacteria puts immense strain on public health. The discovery of new antibiotics that work through unique mechanisms is one important pillar toward combating this threat of resistance. A functionalized amino dihydropyrimidine was reported to exhibit antibacterial activity via the inhibition of dihydrofolate reductase, an underexploited antibacterial target. Despite this promise, little is known about its structure-activity relationships (SAR) and mechanism of activity. Toward this goal, the aza-Biginelli reaction was optimized to allow for the preparation of focused libraries of functionalized amino dihydropyridines, which in some cases required the use of variable temperature NMR analysis for the conclusive assignment of compound identity and purity. Antibacterial activity was examined using microdilution assays, and compound interactions with dihydrofolate reductase were assessed using antimicrobial synergy studies alongside enzyme kinetics, differential scanning fluorimetry, and protein crystallography. Clear antibacterial SAR trends were unveiled (MIC values from >64 to 4 μg/mL), indicating that this compound class has promise for future development as an antibacterial agent. Despite this, the biochemical and biophysical studies performed alongside the synergy assays call the antibacterial mechanism into question, indicating that further studies will be required to fully evaluate the antibacterial potential of this compound class.

Citing Articles

Evaluation of Antibacterial Functionalized Dihydropyrimidine Photoaffinity Probes Toward Mechanism of Action Studies.

Russo C, Boyer Z, Scheunemann K, Farren J, Minich A, Wenthur C ACS Med Chem Lett. 2024; 15(7):1094-1101.

PMID: 39015283 PMC: 11247627. DOI: 10.1021/acsmedchemlett.4c00173.


Scalable and Chromatography-Free Synthesis of Efflux Pump Inhibitor Phenylalanine Arginine β-Naphthylamide for Its Validation in Wild-Type Bacterial Strains.

Russo C, Howey K, OReilly M ChemMedChem. 2023; 18(14):e202300128.

PMID: 37126222 PMC: 10524873. DOI: 10.1002/cmdc.202300128.


Diastereoselective synthesis of cyclic tetrapeptide pseudoxylallemycin A illuminates the impact of base during macrolactamization.

Fumo V, Roberts R, Zhang J, OReilly M Org Biomol Chem. 2023; 21(5):1056-1069.

PMID: 36628602 PMC: 11311250. DOI: 10.1039/d2ob02126a.

References
1.
Reeve S, Scocchera E, G-Dayanadan N, Keshipeddy S, Krucinska J, Hajian B . MRSA Isolates from United States Hospitals Carry dfrG and dfrK Resistance Genes and Succumb to Propargyl-Linked Antifolates. Cell Chem Biol. 2016; 23(12):1458-1467. PMC: 5228619. DOI: 10.1016/j.chembiol.2016.11.007. View

2.
Lombardo M, G-Dayanandan N, Keshipeddy S, Zhou W, Si D, Reeve S . Structure-Guided In Vitro to In Vivo Pharmacokinetic Optimization of Propargyl-Linked Antifolates. Drug Metab Dispos. 2019; 47(9):995-1003. PMC: 7184189. DOI: 10.1124/dmd.119.086504. View

3.
Kaur R, Chaudhary S, Kumar K, Gupta M, Rawal R . Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review. Eur J Med Chem. 2017; 132:108-134. PMC: 7115489. DOI: 10.1016/j.ejmech.2017.03.025. View

4.
Mahgoub S, El-Sayed M, El-Shehry M, Mohamed Awad S, Mansour Y, Fatahala S . Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19. Bioorg Chem. 2021; 116:105272. PMC: 8403975. DOI: 10.1016/j.bioorg.2021.105272. View

5.
Nilsson B, Overman L . Concise synthesis of guanidine-containing heterocycles using the Biginelli reaction. J Org Chem. 2006; 71(20):7706-14. PMC: 2535792. DOI: 10.1021/jo061199m. View